海角黑料

You are here:  

• Print

Resources 

2024 symposium

• 7th Symposium on Primary Breast Cancer in Older Women in Future Oncology

Presentations

• Session 1 - Challenges in clinical trial participation
• Session 1 - Updates
• Session 2 - Adjuvant robotic stereotactic accelerated partial breast irradiation 
• Session 2 - Degree of frailty impacts treatment and outcomes of breast cancer
• Session 2 - G8 in breast cancer survivorship: a protocol for risk stratified survivorship care for older adults
• Session 2 - Uptake of post mastectomy immediate breast reconstruction in older women
• Session 3 - Neoadjuvant endocrine therapy - the Edinburgh experience
• Session 3 - Polypharmacy - Is it relevant?
• Session 4 - Involving patients and caregivers
• Session 4 - Conclusion - Summary and ways forward

2022 symposium

•  in Future Oncology

Presentations

• Session 1 - Management of Breast Cancer in Older women Genomics
• Session 1 - EUSOMA/SIOG Recommendations
• Session 2 - Factors affecting uptake of past-mastectomy immediate breast reconstruction in older women - A systematic review
• Session 2 - Adjuvant chemoterapy and trastuzumab for human epidermal growth receptor 2 positive early invasive breast cancer among older women in England: a population based cohort study using routine date
• Session 2 - Correlation of ER, PR, Nodal Status, and Nottingham Prognostic Index with Oncotype Recurrence score in older women with breast cancer. Was there any impact on offer of chemotherapy?
• Session 2 - Looking at the increased use of Neoadjuvant Endocrine Therapy in the Elderly Population during the Covid-19 pandemic
• Session 4 - Can the anaesthetist and geriatrician work together? An anaesthetist's perspective
• Session 4 - Decision making in frail patients with breast cancer
• Session 4 - The frail patient with breast cancer: risk, planning and optimization - from the geriatrician's perspective

2019 symposium

•  in Future Oncology

Presentations

• Session 1 - Global perspectives - Breast Cancer in Older Patients: What is new?
• Session 1 - National Initiatives to improve the cancer care of older adults
• Session 1 - Bridging the age gap: Treatment variation and outcomes in older women with breast cancer
• Session 2 - The Process Evaluation of the Bridging the Age Gap in Breast Cancer decision support intervention cluster randomised trial
• Session 2 - Pectoral nerve blocks (PECS) and sedation: a way to avoid general anaesthesia in breast surgery. Our Early Experience with Elderly patients
• Session 2 - Decision making in older women with primary breast cancer: the trade-off of the risks and benefits of treatments
• Session 2 - Cytoplasmic cyclin E is an independent marker of agressive tumour biology and breast cancer-specific mortality in older women
• Session 2 - Routine HER2 testing in patients aged over 80 - is it a step too far?
• Session 3 - Approach to dementia - patients with breast cancer
• Session 4 - Challenges in screening: the management of DCIS
• Session 4 - The pros and cons of screening women over 70 years
• Session 4 - Behaviour of DCIS (in the older population)

2017 symposium

• in Future Oncology

Presentations

• Session 1 - Selecting for chemotherapy - the use of genomics
• Session 1 - Selecting for radiotherapy
• Session 2 - Geriatrician in the peroperative assessment clinic
• Session 2 - A joint geriatric oncology clinic for the management of elderly women diagnosed with breast cancer: the Brighton experience
• Session 2 - The management of breast cancer in elderly patients - a local audit
• Session 2 - Elders with breast cancer tend to delay seeking medical care and present with a later cancer stage
• Session 2 - Potential impact of treatment on the mood of older women with primary breast cancer
• Session 3 - The role of the geriatric oncology nurse
• Session 4 - HER2+ Breast cancer in elderly
• Session 4 - Selecting for breast reconstruction 

2015 symposium

•  in Future Oncology

2010 symposium